Skip to main content
See every side of every news story
Published • loading... • Updated

Biogen: M&A Growth And Alzheimer's Progress Are Now Priced In (Rating Downgrade)

Summary by Seeking Alpha
Analyst rates Biogen Inc. a Hold after a 20% gain: $241.38 DCF value at 3.5% growth is near the price, which reflects growth and modest Alzheimer's progress.

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal